Skip to main content

Table 3 Overall medications prescribed

From: Diabetes, hypertension and dyslipidemia medication prescribing in Qatari primary care settings: a retrospective analysis of electronic medical records

Diagnosis

Medication

ATC code

N

%

Hypertension

Angiotensin-converting enzyme inhibitors, plain

[C09AA]-

69,409

8.3

Dihydropyridine derivatives

[C08CA]-

55,356

6.6

Angiotensin II antagonists, plain

[C09CA]-

40,709

4.9

Beta blocking agents, plain, selective

[C07AB]-

31,336

3.7

Angiotensin-converting enzyme inhibitors and diuretics

[C09BA]-

24,463

2.9

Angiotensin II antagonists and diuretics

[C09DA]-

21,569

2.6

Angiotensin-converting enzyme inhibitors and calcium channel blockers

[C09BB]-

15,887

1.9

Sulfonamides, plain (low ceiling diuretics)

[C03BA]-

15,143

1.8

Angiotensin II antagonists and calcium channel blockers

[C09DB]-

14,710

1.8

Sulfonamides, plain (high ceiling diuretics)

[C03CA]-

3779

0.4

Alpha and beta blocking agents

[C07AG]-

3178

0.4

Beta blocking agents, selective, and thiazides

[C07BB]-

2308

0.3

Thiazides, plain

[C03AA]-

2038

0.2

Beta blocking agents, plain, non-selective

[C07AA]-

1654

0.2

Clonidine and analogues

[C02AC

849

0.1

Methyldopa

[C02AB]-

698

0.1

Total

303,086

36.2

T2DM

Biguanides

[A10BA]-

115,690

13.8

Sulfonamides, urea derivatives

[A10BB]-

88,935

10.6

Combinations of oral blood glucose lowering drugs

[A10BD]-

62,340

7.4

Insulins and analogues for injection, long-acting

[A10AE]-

28,457

3.4

Dipeptidyl peptidase 4 (dpp-4) inhibitors

[A10BH]-

25,246

3.0

Insulins and analogues for injection, intermediate-acting combined with fast-acting

[A10AD]-

13,686

1.6

Insulins and analogues for injection, fast-acting

[A10AB]-

11,594

1.4

Thiazolidinediones

[A10BG

11,405

1.4

Insulins and analogues for injection, intermediate-acting

[A10AC]-

2688

0.3

Other oral blood glucose lowering drugs

[A10BX]-

1095

0.1

Glucagon-like peptide-1 (GLP-1) analogues

[A10BJ]-

433

0.1

Alpha glucosidase inhibitors

[A10BF]-

308

0.0

Total

361,877

43.2

Dyslipidaemia

HMG-CoA reductase inhibitors

[C10AA]-

169,301

20.2

Other lipid modifying agents

[C10AX]-

2679

0.3

Fibrates

[C10AB]-

183

0.0

Total

172,163

20.5

Grand total

837,126